Three Strategic Pillars
Health Access
Benefits
Footprint
Action
Breakthrough of the first domestic artificial ligament
In 2023, Ligatech successfully launched the first domestic artificial ligament, breaking the 20-year market monopoly of imported artificial ligaments. This product is optimized for the Asian body shape characteristics,As no autologous tendon harvesting is required, donor-site morbidity associated with graft harvesting is avoided, which may facilitate early post-operative rehabilitation.
By participating in national and provincial volume-based procurement programs, we improve access to innovative implants and help reduce the financialburden on patients. Collaborative technological innovation enables accurate diagnosis and evaluation equipment and AI intelligent diagnosis and treatment tools to reach the grassroots level, assisting grassroots doctors to improve diagnostic efficiency and accuracy, achieve unified and standardized surgical procedures, and improve surgical success rates
Talents are the most valuable asset of an enterprise.
We bring together multi-disciplinary technical professionals, provide continuous career development pathways, actively participate in industry academic exchange and training, encourage continuous learning and innovation among the team, and promote a people-oriented management culture that values the physical and mental health of employees.
Our multi-disciplinary professional technical team works together with experts from key sports medicine departments and universities to complete innovative product R&D.
The 8,661.3 sqm Class 100,000 cleanroom manufacturing facility workshop adopts an energy-saving design, continuously optimizing processes to reduce energy consumption. Product packaging optimization and supply chain collaboration reduce waste, and strict environmental standards ensure compliant disposal of pollutants.
From clinical needs to R&D design, clinical validation, post-launch follow-up, and continuous improvement, we form a collaborative closed loop of "industry, academia, research, and medicine" to accelerate innovation implementation.
The Company collaborates with sports medicine departments of multiple tertiary hospitals and university research teams in China on clinical research and technical development.
